High-density lipoproteins (HDL) are a negative (protective) risk factor for cardiovascular disease. There has been great interest in how the remodeling of HDL by plasma factors might contribute to cardioprotection. A phospholipid transfer protein (PLTP) in human plasma is a key protein in the remodeling of HDL. Although recent studies have shown that PLTP modifies HDL structure and composition even in the absence of other plasma factors, the mechanism by which this occurs remains to be elucidated. We propose three aims that will test eight hypotheses concerning the remodeling mechanism. They are as follows:
Aim 1 : To identify the mechanism(s) by which PLTP remodels HDL, according to the following hypotheses: a] The remodeling of HDL is specific for apolipoprotein (apo) A-I. b] PLTP-independent HDL fusion occurs through a hydrophobic patch on the HDL surface. c] HDL3 fusion, which follows PLTP-mediated apo A-I release and patch formation, is independent of PLTP. d] Fusion but not lipid transfer is inhibited by a net positive or negative charge on HDL. e] The small HDL formed by PLTP are preferential acceptors for cholesterol and a preferred substrate for LCAT. f] Phospholipid transfer is an obligatory precursor of cholesteryl ester transfer.
Aim 2 : To identify the determinants of PLTP molecular transfer specificity.
This aim will address the hypothesis that the molecular specificity of PLTP is determined by its affinity for and binding to monomeric lipid.
Aim 3 : To identify the effects of PLTP on the interaction of plasma lipoproteins with macrophage-derived lipoproteins.
This aim will address the hypothesis that PLTP is a key mediator of the association of macrophage-derived lipoproteins with more mature forms of HDL. The major techniques to be employed are site-directed mutagenesis, assays of lecithin:cholesterol acyltransferase and phospholipase activity, tissue culture (P388D1 macrophages), equilibrium measurements and lipid and protein assays.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL056865-06
Application #
6621415
Study Section
Special Emphasis Panel (ZRG1-SSS-T (01))
Program Officer
Wassef, Momtaz K
Project Start
1997-04-01
Project End
2006-03-31
Budget Start
2003-04-01
Budget End
2004-03-31
Support Year
6
Fiscal Year
2003
Total Cost
$338,625
Indirect Cost
Name
Baylor College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Gillard, Baiba K; Rosales, Corina; Xu, Bingqing et al. (2018) Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins. J Clin Lipidol 12:849-856
Xu, Bingqing; Gillard, Baiba K; Gotto Jr, Antonio M et al. (2017) ABCA1-Derived Nascent High-Density Lipoprotein-Apolipoprotein AI and Lipids Metabolically Segregate. Arterioscler Thromb Vasc Biol 37:2260-2270
Jarrett, Kelsey E; Lee, Ciaran M; Yeh, Yi-Hsien et al. (2017) Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease. Sci Rep 7:44624
Gillard, Baiba K; Bassett, G Randall; Gotto Jr, Antonio M et al. (2017) Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester. J Biol Chem 292:8864-8873
Yelamanchili, Dedipya; Gillard, Baiba K; Gotto Jr, Antonio M et al. (2017) Structural Stability of Streptococcal Serum Opacity Factor. Protein J 36:196-201
Rosales, C; Davidson, W S; Gillard, B K et al. (2016) Speciated High-Density Lipoprotein Biogenesis and Functionality. Curr Atheroscler Rep 18:25
Gillard, Baiba K; Rodriguez, Perla J; Fields, David W et al. (2016) Streptococcal serum opacity factor promotes cholesterol ester metabolism and bile acid secretion in vitro and in vivo. Biochim Biophys Acta 1861:196-204
Rodriguez, Perla J; Gillard, Baiba K; Barosh, Rachel et al. (2016) Neo High-Density Lipoprotein Produced by the Streptococcal Serum Opacity Factor Activity against Human High-Density Lipoproteins Is Hepatically Removed via Dual Mechanisms. Biochemistry 55:5845-5853
Pownall, Henry J; Gotto Jr, Antonio M (2016) New Insights into the High-Density Lipoprotein Dilemma. Trends Endocrinol Metab 27:44-53
Murray, Stephen C; Gillard, Baiba K; Ludtke, Steven J et al. (2016) Direct Measurement of the Structure of Reconstituted High-Density Lipoproteins by Cryo-EM. Biophys J 110:810-6

Showing the most recent 10 out of 68 publications